Aerosolized therapy for hemoglobin toxicity in the treatment of hemolytic diseases

Related grants

Same researchers, same institution, same topic, scored first.

• NIH · Pennsylvania State University, theNot yet scored

  Preclinical Evaluation of a Peptide-amphiphile Derived Toroidal Oxygen Carrier

  Narayana Aluru · $715K · 2025–2028

• NIH · University of Maryland BaltimoreNot yet scored

  Bioengineering a novel therapeutic protein complex to minimize the effects of medical device induced hemolysis

  Paul Werner Buehler · $632K · 2022–2026

• NIH · University of Colorado DenverNot yet scored

  The paradoxical response to iron in pulmonary hypertension of sickle cell disease

  Paul Werner Buehler · $667K · 2022–2027

• NIH · University of Colorado Denver70

  Impact of Aiolos on intestinal intraepithelial lymphocytes

  Kentaro Yomogida · $162K · 2022–2027

• NIH · University of Colorado Denver65

  Administrative supplement to Exosome Biomarkers in concussion and Alzheimer's.

  Ann-Charlotte Esther Granholm-Bentley · $107K · 2021–2026

• NIH · University of Colorado Denver62

  How do astrocytes remodel the nervous system?

  Yunsik Kang · $224K · 2022–2027

• NIH · University of Colorado Denver61

  Rescuing neurovascular coupling to protect neuronal plasticity and cognition

  Fabrice Dabertrand · $572K · 2022–2027

• NIH · University of Colorado Denver59

  Neurovascular unit dysfunction in Down syndrome revealed by TBI

  Mingxia Huang · $738K · 2022–2027

• NIH · University of Colorado Denver58

  The role of myelination in cortical circuit function and motor behavior

  Ethan Garrett Hughes · $571K · 2020–2029

• NIH · Johns Hopkins UniversityNot yet scored

  Alpha-Emitter Therapy of Osteosarcoma

  Dara L Kraitchman · $666K · 2024–2029

• NSF · North Dakota State University Fargo76

  RII Track-4: NSF: Data-driven Computational and Machine Learning Assessment of Structure-Toxicity Relationship of Micro/NanoPlastics

  Bakhtiyor Rasulev · $192K · 2023–2025

• NIH · University of Iowa64

  A precision medicine approach to improve prediction of severe toxicity in fluorouracil chemotherapy

  Steven Offer · $358K · 2024–2026

• NIH · Oregon State University64

  Linking PAH Exposure to Health Outcomes Using Human Primary In Vitro Respiratory Model

  Susan C Tilton · $266K · 2009–2030

• NSF · Virginia Polytechnic Institute and State University63

  SaTC: CORE: Small: Systematic Threat Characterization and Prevention in Open-Domain Dialog Systems

  Bimal Viswanath · $600K · 2023–2026

• NIH · Case Western Reserve University51

  Deubiquitinase USP19 in TDP-43 pathogenesis.

  David E Kang · $596K · 2022–2027